Glucagon-like peptide-1 secretory function as an independent determinant of blood pressure: analysis in the Tanno-Sobetsu study.

Glucagon-like peptide-1 secretory function as an independent determinant of blood pressure: analysis in the Tanno-Sobetsu study.

AIMS: Roles of glucagon-like peptide-1 (GLP-1) in extra-pancreatic tissues remain unclear. The aim of this study was to examine determinants of GLP-1 secretory function and possible contribution of GLP-1 to blood pressure (BP) regulation. METHODS AND RESULTS: We recruited 128 subjects who received a...

Full description

Bibliographic Details
Main Authors:	Mayumi Yoshihara, Hiroshi Akasaka, Hirofumi Ohnishi, Takayuki Miki, Tetsuaki Furukawa, Satoshi Yuda, Shigeyuki Saitoh, Tetsuji Miura
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2013-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC3699646?pdf=render

Similar Items

Insulin Resistance is Associated with Longitudinal Changes of Cardiac Repolarization Heterogeneity in Apparently Healthy Subjects
by: Tamaki Matsumoto, et al.
Published: (2019-07-01)

Increased biogenesis of glucagon-containing secretory granules and glucagon secretion in BIG3-knockout mice
by: Hongyu Li, et al.
Published: (2015-03-01)

Reduction in GLP-1 secretory capacity may be a novel independent risk factor of coronary artery stenosis
by: Chihiro Nagase, et al.
Published: (2021-08-01)

Longitudinal impact of dapagliflozin treatment on ventricular repolarization heterogeneity in patients with type 2 diabetes
by: Tatsuya Sato, et al.
Published: (2019-11-01)

Re “International survey on skin patch test procedures, attitudes and interpretation” L.K. Tanno et al., WAOJ (2016) 9:8
by: Wolfgang Uter, et al.
Published: (2017-01-01)

Re “International survey on skin patch test procedures, attitudes and interpretation” L.K. Tanno et al., WAOJ (2016) 9:8
by: Wolfgang Uter, et al.
Published: (2017-04-01)

Elevated circulating FABP4 concentration predicts cardiovascular death in a general population: a 12-year prospective study
by: Norie Saito, et al.
Published: (2021-02-01)

Fatty Acid-Binding Protein 4 (FABP4): Pathophysiological Insights and Potent Clinical Biomarker of Metabolic and Cardiovascular Diseases
by: Masato Furuhashi, et al.
Published: (2015-02-01)

Fatty Acid-Binding Protein 4 (FABP4): Pathophysiological Insights and Potent Clinical Biomarker of Metabolic and Cardiovascular Diseases
by: Masato Furuhashi, et al.
Published: (2014-01-01)

Independent links between plasma xanthine oxidoreductase activity and levels of adipokines
by: Masato Furuhashi, et al.
Published: (2019-07-01)

Urinary excretion of fatty acid-binding protein 4 is associated with albuminuria and renal dysfunction.
by: Yusuke Okazaki, et al.
Published: (2014-01-01)

Circulating levels of fatty acid-binding protein family and metabolic phenotype in the general population.
by: Shutaro Ishimura, et al.
Published: (2013-01-01)

Drug Development Targeting the Glycogen Synthase Kinase-3β (GSK-3β)-Mediated Signal Transduction Pathway: Role of GSK-3β in Myocardial Protection Against Ischemia/Reperfusion Injury
by: Tetsuji Miura, et al.
Published: (2009-01-01)

Serum FABP5 concentration is a potential biomarker for residual risk of atherosclerosis in relation to cholesterol efflux from macrophages
by: Masato Furuhashi, et al.
Published: (2017-03-01)

Estimated Daily Intake and Seasonal Food Sources of Quercetin in Japan
by: Haruno Nishimuro, et al.
Published: (2015-04-01)

Glucagon Receptor Signaling and Glucagon Resistance
by: Lina Janah, et al.
Published: (2019-07-01)

Synthesis of a possible glucagon inhibitor by semisynthesis of a glucagon analogue of [HARG¹²]-glucagon and [DES-HIS¹][HARG¹²]-glucagon
by: Lo, Suzanne Sin-Mui
Published: (1980)

Effects of diabetes on myocardial infarct size and cardioprotection by preconditioning and postconditioning
by: Miki Takayuki, et al.
Published: (2012-06-01)

Glucagon-like peptide 2 (GLP-2) in bovine colostrum and transition milk
by: Yudai Inabu, et al.
Published: (2021-05-01)

Role of Macronutrients in the Regulation and Secretory Mechanisms of Gastrointestinal Hormones, Glucagon-like Peptide-1 (GLP-1) and Glucose-dependent Insulinotropic Polypeptide (GIP), in Lymph
by: Lu, Wendell J.
Published: (2008)

Physical Activity during Winter in Old-Old Women Associated with Physical Performance after One Year: A Prospective Study
by: Atsushi Mizumoto, et al.
Published: (2015-01-01)

Transgenic Expression of Glucagon-Like Peptide-1 (GLP-1) and Activated Muscarinic Receptor (M3R) Significantly Improves Pig Islet Secretory Function
by: Nizar I. Mourad, et al.
Published: (2017-05-01)

Revisiting the Pharmacological Value of Glucagon: An Editorial for the Special Issue “The Biology and Pharmacology of Glucagon”
by: Timo D. Müller, et al.
Published: (2020-01-01)

Beginning of a new era in glucagon research: Breakthrough by the new glucagon assay
by: Dan Kawamori
Published: (2020-09-01)

Studies on protein synthesis in secretory and non-secretory tissues
by: Andrews, T. M.
Published: (1969)

Differential regulation of hypoxanthine and xanthine by obesity in a general population
by: Masato Furuhashi, et al.
Published: (2020-07-01)

Central administration of glucagon suppresses food intake in chicks
by: Honda, Kazuhisa, et al.
Published: (2007)

Glucagon-Like Peptide-1
by: Joel P. Giblett, BM, BSc, et al.
Published: (2016-06-01)

Signal Transduction of Glucagon Secretion
by: Vieira, Elaine
Published: (2006)

Metabolic effects of glucagon in humans
by: María M. Adeva-Andany, et al.
Published: (2019-03-01)

Glucagon Regulation of Energy Expenditure
by: Maximilian Kleinert, et al.
Published: (2019-10-01)

Glucagon, GLP-1 and Thermogenesis
by: Ismael González-García, et al.
Published: (2019-07-01)

An investigation into glucagon receptor pharmacology
by: Barkan, Kerry
Published: (2017)

Secretory meningioma
by: Xiao-ling YAN
Published: (2013-05-01)

Secretory meningioma
by: YAN Xiao-ling
Published: (2013-05-01)

Lymph Node Dissection in Curative Gastrectomy for Advanced Gastric Cancer
by: Shigeyuki Tamura, et al.
Published: (2011-01-01)

Distinct impacts of sleep-disordered breathing on glycemic variability in patients with and without diabetes mellitus.
by: Kei Nakata, et al.
Published: (2017-01-01)

Studies of glucagon resistance in large rat adipocytes: 125I-labeled glucagon binding and lipolytic capacity
by: James N. Livingston, et al.
Published: (1974-01-01)

Methods and Guidelines for Measurement of Glucagon in Plasma
by: Jens J. Holst, et al.
Published: (2019-10-01)

Mechanisms of the Regulation and Dysregulation of Glucagon Secretion
by: Arnold N. Onyango
Published: (2020-01-01)